In the same tumor model and under identical treatment conditions, IFN-γ ELISPOT assays on splenocytes (Fig. 5c) demonstrated robust antigen-specific T-cell responses largely mediated by CD8+ effector cells, suggesting that infiltrating CD8+ T cells were functional and contributed to tumor regression. The gene discussed is IFNG; the disease is neoplasm.